help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2004-2512
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verhaeghe, J.
Right arrow Articles by Coopmans, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verhaeghe, J.
Right arrow Articles by Coopmans, W.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Pediatric Endocrinology
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 6 3449-3453
Copyright © 2005 by The Endocrine Society

Exogenous Corticosteroids and in Utero Oxygenation Modulate Indices of Fetal Insulin Secretion

Johan Verhaeghe, Rita van Bree, Erik van Herck and Willy Coopmans

Department of Obstetrics and Gynecology (J.V., R.v.B.), and Laboratorium voor Experimentele Geneeskunde en Endocrinologie (E.v.H., W.C.), Katholieke Universiteit Leuven, 3000 Leuven, Belgium

Address all correspondence and requests for reprints to: Johan Verhaeghe, M.D., Department of Obstetrics and Gynecology, U.Z. Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. E-mail: johan.verhaeghe{at}uz.kuleuven.ac.be.

Low birth weight has long-term effects on glucose-insulin homeostasis. Factors that could mediate intra-uterine "programing" of glucose homeostasis include endogenous and exogenous glucocorticoids, adipose tissue-secreted factors such as adiponectin, and in utero hypoxia. Here, we studied 123 fetuses with gestational age (GA) between 25 and 37 wk and birth weight SD score (BW SDS) between –2.79 and 2.42. We measured proinsulin, C-peptide, insulin, and adiponectin in umbilical vein (UV) plasma and calculated the proinsulin to insulin ratio as a measure of ß-cell secretory function. These indices were related to GA, BW SDS, time since the last maternal betamethasone administration, and blood gas data.

Insulin and C-peptide were correlated with BW SDS but not GA, whereas the proinsulin to insulin ratio was inversely correlated with BW SDS. The proinsulin to insulin ratio was raised (P = 0.002) in fetuses with UV PO2 less than or equal to 21.3 mm Hg (i.e. the 50th percentile) compared with those with PO2 more than 21.3 mm Hg, inferring that in utero hypoxia engenders ß-cell secretory dysfunction. Proinsulin, insulin, and C-peptide were markedly but transiently (<24 h) elevated after maternal betamethasone administration, returning thereafter to concentrations measured in noncorticosteroid-treated fetuses. However, there was considerable variability within the less than 24-h betamethasone group: the indices of insulin secretion were related to UV PO2, suggesting that hypoxia attenuates the responsiveness of fetal ß-cells to corticosteroids. Adiponectin was not related to any of the insulin indices.

In conclusion, we have identified two environmental signals that modulate fetal insulin output: maternal corticosteroids produce a transient surge in fetal insulin synthesis and secretion, whereas in utero hypoxia disturbs the insulin secretory process.




This article has been cited by other articles:


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
M J J Finken, M G Keijzer-Veen, F W Dekker, M Frolich, F J Walther, J A Romijn, B J van der Heijden, J M Wit, and on behalf of the Dutch POPS-19 Collaborative Study
Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2008; 93(6): F442 - F447.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. A. Owens, K. L. Gatford, M. J. De Blasio, L. J. Edwards, I. C. McMillen, and A. L. Fowden
Restriction of placental growth in sheep impairs insulin secretion but not sensitivity before birth
J. Physiol., November 1, 2007; 584(3): 935 - 949.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton
Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev., April 1, 2006; 27(2): 141 - 169.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society